| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Atropine sulfate (substance) |
Is a |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine measurement |
Component |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Poisoning caused by atropine (disorder) |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental atropine poisoning |
Causative agent (attribute) |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional atropine poisoning |
Causative agent (attribute) |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par l'atropine d'intention indéterminée |
Causative agent (attribute) |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine allergy |
Causative agent (attribute) |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine overdose |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental atropine overdose |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional atropine overdose |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose d'atropine d'intention indéterminée |
Causative agent (attribute) |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Methylatropine nitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing atropine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine eye preparations (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine 2mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine sulfate + diphenoxylate hydrochloride 0.025mg/2.5mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing atropine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Morphine sulfate+atropine sulfate 10mg/600micrograms/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Morphine sulfate+atropine sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing atropine and pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine/pralidoxime two auto-injectors injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine/pralidoxime single auto-injector solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine 2.1mg/pralidoxime 600mg single auto-injector solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine 2mg/pralidoxime 600mg two auto-injectors solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine penalization therapy for amblyopia (procedure) |
Direct substance |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional atropine poisoning |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine methonitrate |
Is a |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental poisoning by atropine |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine allergy |
Causative agent (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atropine methonitrate |
Is modification of (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Atropine sulfate (substance) |
Is modification of (attribute) |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atropine- and hyoscine- and hyoscyamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atropine- and diphenoxylate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atropine- and diphenoxylate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing atropine and difenoxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine- and difenoxin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine- and pralidoxime-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing atropine and edrophonium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing atropine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atropine and edrophonium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atropine and hyoscyamine and scopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Atropine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine and difenoxin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine and diphenoxylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only atropine and pralidoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atropine and difenoxin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atropine and diphenoxylate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only atropine and hyoscyamine and scopolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only atropine and pralidoxime in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only atropine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Atropine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atropine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]